Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Lantern Pharma Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 33 | 39 | +6 |
| Shares | 2.10M | 2.88M | +786.2K (+37.5%) |
| Value | $2.87M | $12.0M | +$9.15M (+318.5%) |
New holders (12)
Institutions that held Lantern Pharma Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Empery Asset Management, LP | 842,669 | $3.51M | 4.06% |
| Citadel Advisors LLC | 47,895 | $199.7K | 0.00% |
| Quadrature Capital Ltd | 39,593 | $165.1K | 0.00% |
| XTX Topco Ltd | 17,415 | $72.6K | 0.00% |
| Susquehanna International Group, LLP | 14,073 | $58.7K | 0.00% |
| Marshall Wace, LLP | 11,946 | $49.8K | 0.00% |
| Farther Finance Advisors, LLC | 10,975 | $45.8K | 0.00% |
| Entrust Financial LLC | 500 | $2.08K | 0.00% |
| UMA Financial Services, Inc. | 158 | $659 | 0.00% |
| Rialto Wealth Management, LLC | 123 | $513 | 0.00% |
| PlanVest Financial, Inc | 100 | $417 | 0.00% |
| Barclays PLC | 6 | $25 | 0.00% |
Sold out (6)
Institutions that held Lantern Pharma Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Voss Capital, LLC | 50,000 | $68.5K |
| Curio Wealth, LLC | 2,000 | $2.74K |
| Wells Fargo & Company | 1,475 | $2.02K |
| FMR LLC | 500 | $685 |
| JPMorgan Chase & Co | 97 | $120 |
| Citigroup Inc | 45 | $62 |